PHIO

Conviction 20HealthcareScan · Thu, Jun 25, 2026

PHIO$0.9649-5.40%

ResistanceSupportVol 14

Vol MA14 257.77K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Phio Pharmaceuticals Corp.PHARMACEUTICAL PREPARATIONSwww.phiopharma.com ↗

Price0.9649

Change-5.40%

Gap+0.49%

Rel volume4.70×

Avg volume217.24K

Avg $ vol228.37K

SMA 201.08

SMA 501.13

SMA 2001.38

Price vs 50-14.28%

Price vs 200-29.96%

MA stackbearish

50/200 cross—

Supertrenddown · 1.14

RSI (14)34

MACD hist-0.01

MACD crossbear · 4d

Stoch %K / %D0 / 4

ADX (14)19

+DI / −DI11 / 27

RSI divergence—

MACD divergence—

ATR %+5.12%

ADR %4.33%

52w high2.74

52w low0.8568

From 52w high-64.78%

Above 52w low+12.62%

New 52w highNo

SqueezeOff

Bollinger width15.88%

%B-0.15

Donchian pos0.00%

Donchian high1.15

Donchian low0.9649

AVWAP (52w high)1.77

vs AVWAP high-45.53%

AVWAP (52w low)1.27

vs AVWAP low-24.17%

OBV trendDown

Chaikin MF (20)-0.47

Today vs 20d4.70×

Avg vol (14d)257.77K

Avg vol (20d)217.24K

Avg $ vol (20d)228.37K

Market cap11.21M

RS 3m (vs SPY)-28.65%

RS 6m (vs SPY)-12.41%

RS line new highNo

Trend template0/8

Technical rank17.0

1 week-10.66%

1 month-10.66%

3 months-23.42%

6 months-12.28%

1 year-56.34%

YTD-11.48%

P/E-1.29

P/B0.68

P/S—

P/FCF-1.40

EPS-9.08

Div yield—

ROE-52.84%

ROA-49.95%

Debt/Eq0.00

Current14.43

EV/EBITDA0.63

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-21.65%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-5.82M

Revenue0

Net income-4M

Gross profit—

Free cash flow-7.99M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees6

ListedThu, May 10, 2012

Free float11.52M

Float %99.1%

Short interest313.8K

Days to cover3.0d

Short volume39.6%

Squeeze score35 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank17.0 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.15

Support1.04

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PHIO

All disclosures →

No recent disclosed trades by Congress in PHIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PHIO

No recent insider (Form 4) filings in PHIO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in PHIO

EDGAR →

No recent SEC filings on file for PHIO.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.